JRL ISN'T A TRADERS STOCK WITH 35M SHARES ISSUED. IF THERE'S A COMPANY MAKER GOING CHEAP THEN JRL SHOULD TAKE THAT CHANCE.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025